Alendronate-coated long-circulating liposomes containing ^99mtechnetium-ceftizoxime used to identify osteomyelitis

References

• El-ManghrabyTAMoustafaHMPauwelsEKNuclear medicine methods for evaluation of skeletal infection among other diagnostic modalitiesQ J Nucl Med Mol Imaging20065016719216868532
   PubMedGoogle Scholar
• KothariNAPelchovitzDJMeyerJSImaging of musculoskeletal infectionsRadiol Clin North Am20013965367111549164
   PubMed Web of Science ®Google Scholar
• LangSOsteomyelitis: a pathomorphologic overviewRadiologe199636781785 German9036415
   PubMedGoogle Scholar
• RennenHJBoermanOCOyenWJCorstensFHImaging infection/inflammation in the new milenniumEur J Nucl Med20012824125211303896
   PubMedGoogle Scholar
• GratzSRennenHJBoermanOCOyenWJBurmaPCorstensFH(99m)Tc-interleukin-8 for imaging of acute osteomyelitisJ Nucl Med2001421257126411483689
   PubMedGoogle Scholar
• SignoreAD’ AlessandriaCAnnovazziAScopinaroFRadiolabeled cytokines for imaging chronic inflammationBrazilian Archives of Biology and Technology2002451523
   Google Scholar
• PalestroCJLoveCMillerTTDiagnostic imaging tests and microbial infectionsCell Microbiol200792323233317645552
   PubMedGoogle Scholar
• LoveCPalestroCJRadionuclide imaging of infectionJ Nucl Med Technol200432475715175400
   PubMedGoogle Scholar
• BenitezARocaMMartin-CominJLabeling of antibiotics for infection diagnosisQ J Nucl Med Mol Imaging20065014715216770305
   PubMed Web of Science ®Google Scholar
• PinedaCVargasVRodríguezAVImaging of osteomyelitis: current conceptsInfect Dis Clin North Am20062078982517118291
   PubMed Web of Science ®Google Scholar
• WarehamDMichaelJDasSAdvances in bacterial specific imagingBrazilian Archives of Biology and Technology200548145152
   Google Scholar
• DinizSORezendeCMSerakidesRScintigraphic imaging using technetium-99m-labeled ceftizoxime in an experimental model of acute osteomyelitis in ratsNucl Med Commun20082983083618677212
   PubMedGoogle Scholar
• BoermanOCDansETOyenWJCorstensFHStormGRadiopharmaceuticals for scintigraphic imaging of infection and inflammationInflamm Res200150556411289655
   PubMed Web of Science ®Google Scholar
• CarmoVASde OliveiraMCMotaLGFreireLPFerreiraRLBCardosoVNTechnetium-99m-labeled stealth pH-sensitive liposomes: a new strategy to identify infection in experimental modelBrazilian Archives of Biology and Technology200750199207
   Google Scholar
• OyenWJBoermanOCStormGDetecting infection and inflammation with technetium-99m-labeled Stealth liposomesJ Nucl Med199637139213978708782
   PubMed Web of Science ®Google Scholar
• FerreiraSMDomingosGPFerreira DdosSTechnetium-99m-labeled ceftizoxime loaded long-circulating and pH-sensitive liposomes used to identify osteomyelitisBioorg Med Chem Lett2012224605460822726927
   PubMed Web of Science ®Google Scholar
• RogersMJFrom molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonatesCalcif Tissue Int20047545146115332174
   PubMed Web of Science ®Google Scholar
• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• WangGThanouMTargeting nanoparticles to cancerPharmacological Research201062909920380880
   PubMed Web of Science ®Google Scholar
• TorchilinVPTargeted pharmaceutical Nnanocarriers for cancer therapy and ImagingAAPS J20079E128E14717614355
   PubMed Web of Science ®Google Scholar
• RusselRGWattsNBEbetinoFHRogersMJMechanisms of action of biphosphonates: similarities and differences and their potential influence on clinical efficacyOsteoporosis Int200819733759
   Google Scholar
• SchottHGoltzDSchottTCJauchCSchwendenerRCN4-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine-new drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate)Bioorg Med Chem2011193520352621536448
   PubMed Web of Science ®Google Scholar
• AnadaTTakedaYHondaYSakuraiKSuzukiOSynthesis of calcium phosphate-binding liposome for drug deliveryBioorg Med Chem Lett2009194148415019523821
   PubMed Web of Science ®Google Scholar
• HengstVOussorenCKisselTStormGBone targeting potential of bisphosphonate-targeted liposomes. Preparation, characterization and hydroxyapatite binding in vitroInt J Pharm200733122422717150316
   PubMed Web of Science ®Google Scholar
• SalernoMCenniEFotiaCBone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastasesCurr Cancer Drug Targets20101064965920578992
   PubMed Web of Science ®Google Scholar
• SwamiAReaganMRBastoPEngineered nanomedicine for myeloma and bone microenvironment targetingProc Natl Acad Sci U S A2014111102871029224982170
   PubMed Web of Science ®Google Scholar
• MussiSVSilvaRCOliveiraMCLucciCMAzevedoRBFerreiraLANew approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticlesEur J Pharm Sci20134828229023178339
   PubMed Web of Science ®Google Scholar
• PinkertonNMGrandeuryAFischABrozioJRiebesehlBUPrud’hommeRKFormation of stable nanocarriers by in situ ion pairing during block-copolymer-direct rapid precipitationMol Pharm2013103192823259920
   PubMedGoogle Scholar
• StahlPHWermuthCGHandbook of Pharmaceutical Salts: Properties, Selection and Use1st edWeinheimWhiley-VCH2002
   Google Scholar
• DinizSOFSiqueiraCFNelsonDLMartin-CominJCardosoVN99mTechnetium-ceftizoxime kit preparationBrazilian Archives of Biology and Technology2005488996
   Google Scholar
• HungGUTsaiSCKaoCHLinWYWangSJDisparate results between I-131 and Tc-99m pertechnetate owing to administration of iodine-containing radiographic contrast materialSemin Nucl Med20003014714810787196
   PubMedGoogle Scholar
• ZiessmanHAO’MalleyJPThrallJHFaheyFHNuclear Medicine: The requisites4th edPhiladelphiaElsevier2014
   Google Scholar
• AwasthiVGoinsBKlipperRLoredoRKorvickDPhillipsWTImaging experimental osteomyelitis using radiolabeled liposomesJ Nucl Med199839108910949627351
   PubMedGoogle Scholar
• CrommelinDJvan RensenAJWaubenMHStormGLiposomes in autoimmune diseases: selected applications in immunotherapy and inflammation detectionJ Control Release19996224525110518657
   PubMed Web of Science ®Google Scholar
• ErdoganSOzerAYErcanMTHincalAAScintigraphic imaging of infections with 99m-Tc-labelled glutathione liposomesJ Microencapsul20001745946510898086
   PubMed Web of Science ®Google Scholar
• LitzingerDCBuitingAMvan RooijenNHuangLEffect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomeBiochim Biophys Acta19941190991078110825
   PubMed Web of Science ®Google Scholar
• New RRCLiposomes: a practical approach1st edOxfordOxford University Press1990
   Google Scholar
• KurniawanJYinNNLiuGYKuhlTLInteraction forces between ternary lipid bilayers containing cholesterolLangmuir2014304997500424716859
   PubMedGoogle Scholar
• RanngerCHelbokAvon GuggenbergEInfluence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticlesInt J Nanomedicine201275889590023226020
   PubMedGoogle Scholar
• RauscherAFrindelMMaurelCInfluence of pegylation and hapten location at the surface of radiolabelled liposomes on tumour immunotargeting using bispecific antibodyNucl Med Biol201441Supple66e7424485990
   PubMedGoogle Scholar
• PhillipsWTDelivery of gamma-imaging agents by liposomesAdv Drug Deliv Rev199937133210837724
   PubMed Web of Science ®Google Scholar
• UlrichASBiophysical aspects of using liposomes as delivery vehiclesBiosci Rep20022212915012428898
   PubMed Web of Science ®Google Scholar
• Gomes BarretoVIglesiasFRocaMTubauFMartín-ComínJLabelling of ceftizoxime with 99m-TcRev Esp Med Nucl200019478483 Spanish
   Google Scholar